Machine Learning for CRISPR-Based Diagnostics.

Area of Science:

• CRISPR-based diagnostics
• Computational biology
• Bioinformatics

Background:

• CRISPR diagnostics offer high sensitivity for detecting nucleic acids from viruses, bacteria, and cancers, nearing quantitative PCR performance.
• Current translation to decentralized care is limited by insufficient computational design and interpretation datasets.

Purpose of the Study:

• To review the state of CRISPR-based diagnostics, focusing on computational models and data limitations.
• To map a path forward for advancing CRISPR diagnostics beyond current data constraints.

Main Methods:

• Analysis of deep neural networks for designing Cas13 detection assays and generative deep learning for single-nucleotide discrimination.
• Evaluation of computer vision for lateral flow assay classification and multi-biomarker fusion for cancer detection.
• Synthesis of mechanistic constraints, predictive models, and point-of-care classifiers.

Main Results:

• Cas12a assays achieved 95% positive predictive agreement with RT-qPCR at 10 copies/μL.
• Deep neural networks designed Cas13 assays for 1933 viruses with strong guide ranking correlations (0.69-0.84).
• Generative models improved single-nucleotide discrimination 2-3 fold; computer vision achieved 96.5% accuracy in classifying lateral flow outputs; AUC of 0.998 for lung cancer detection.

Conclusions:

• Despite promising results, CRISPR diagnostics are built on narrow data foundations, limiting predictive model development and validation.
• Future progress necessitates expanding screening libraries, developing more diagnostic models, and validating classifiers on diverse cohorts.
• Evolutionary pretraining and lab-in-the-loop agents are proposed to overcome data limitations and drive targeted data acquisition.